|
BBS7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.263400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.342200E-01 |
| Normal-vs-Stage2 |
4.143000E-01 |
| Normal-vs-Stage3 |
4.49059999996226E-06 |
| Normal-vs-Stage4 |
4.08699999998596E-06 |
| Stage1-vs-Stage2 |
5.572000E-01 |
| Stage1-vs-Stage3 |
1.93680000004637E-06 |
| Stage1-vs-Stage4 |
1.51744999999925E-05 |
| Stage2-vs-Stage3 |
4.611600E-02 |
| Stage2-vs-Stage4 |
3.048100E-02 |
| Stage3-vs-Stage4 |
7.327600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.690260E-02 |
| Normal-vs-AfricanAmerican |
3.227100E-04 |
| Normal-vs-Asian |
9.307600E-01 |
| Caucasian-vs-AfricanAmerican |
5.630200E-02 |
| Caucasian-vs-Asian |
5.621200E-01 |
| AfricanAmerican-vs-Asian |
1.388420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.422100E-03 |
| Normal-vs-Female |
9.256300E-02 |
| Male-vs-Female |
2.181800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.108100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.154390E-01 |
| Normal-vs-Age(61-80Yrs) |
2.236400E-03 |
| Normal-vs-Age(81-100Yrs) |
7.455800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.859800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.239800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.184200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.144040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.307600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.920800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.795600E-02 |
| Normal-vs-Grade 2 |
8.059400E-01 |
| Normal-vs-Grade 3 |
8.10170000000721E-05 |
| Normal-vs-Grade 4 |
4.65759986134628E-10 |
| Grade 1-vs-Grade 2 |
1.399600E-01 |
| Grade 1-vs-Grade 3 |
6.18989999999764E-05 |
| Grade 1-vs-Grade 4 |
8.51389999612095E-08 |
| Grade 2-vs-Grade 3 |
5.18859999965038E-07 |
| Grade 2-vs-Grade 4 |
6.06859007490357E-12 |
| Grade 3-vs-Grade 4 |
5.361000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.436100E-02 |
| Normal-vs-ccB subtype |
7.28890000023519E-07 |
| ccA subtype-vs-ccB subtype |
3.8968828164343E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.951570E-02 |
| Normal-vs-N1 |
1.439610E-03 |
| N0-vs-N1 |
1.070630E-01 |
|
|
